Chen Q, Huo K, Ji S, Pang S, Sun T, Niu Y
Bioeng Transl Med. 2025; 10(2):e10713.
PMID: 40060761
PMC: 11883111.
DOI: 10.1002/btm2.10713.
Qin H, Han Y, Li J, Wu Q, Du Y, Li Q
NPJ Precis Oncol. 2025; 9(1):65.
PMID: 40057617
PMC: 11890584.
DOI: 10.1038/s41698-025-00840-w.
Jeon T, Goswami R, Nagaraj H, Cicek Y, Lehot V, Welton J
Adv Funct Mater. 2025; 34(42).
PMID: 40017807
PMC: 11864752.
DOI: 10.1002/adfm.202406763.
Dong F, Zhou J, Wu Y, Gao Z, Li W, Song Z
Front Cell Dev Biol. 2025; 12:1499111.
PMID: 39882259
PMC: 11774998.
DOI: 10.3389/fcell.2024.1499111.
Tenchov R, Hughes K, Ganesan M, Iyer K, Ralhan K, Lotti Diaz L
ACS Nano. 2025; 19(4):4011-4038.
PMID: 39823199
PMC: 11803921.
DOI: 10.1021/acsnano.4c09566.
Co-delivery of antioxidants and siRNA-VEGF: promising treatment for age-related macular degeneration.
Dias M, Cruz-Cazarim E, Pittella F, Baiao A, Pacheco A, Sarmento B
Drug Deliv Transl Res. 2025; .
PMID: 39751765
DOI: 10.1007/s13346-024-01772-x.
Polymer-siRNA nanovectors for treating lung inflammation.
Goswami R, Nagaraj H, Cicek Y, Nasim N, Mirza S, Hassan M
J Control Release. 2024; 378:1092-1102.
PMID: 39730067
PMC: 11830555.
DOI: 10.1016/j.jconrel.2024.12.053.
Biomimetic mesenchymal stem cell membrane-coated nanoparticle delivery of MKP5 inhibits hepatic fibrosis through the IRE/XBP1 pathway.
Tian Y, Sun D, Liu N, Zhao J, Zhao T, Liu X
J Nanobiotechnology. 2024; 22(1):741.
PMID: 39609656
PMC: 11606114.
DOI: 10.1186/s12951-024-03029-8.
Modulating and Imaging Macrophage Reprogramming for Cancer Immunotherapy.
Wang J, Lu Y, Zhang R, Cai Z, Fan Z, Xu Y
Phenomics. 2024; 4(4):401-414.
PMID: 39583310
PMC: 11584841.
DOI: 10.1007/s43657-023-00154-6.
Phase-separating peptide coacervates with programmable material properties for universal intracellular delivery of macromolecules.
Sun Y, Wu X, Li J, Radiom M, Mezzenga R, Verma C
Nat Commun. 2024; 15(1):10094.
PMID: 39572548
PMC: 11582321.
DOI: 10.1038/s41467-024-54463-z.
STAT3: Key targets of growth-promoting receptor positive breast cancer.
Jiang R, Zhu J, Zhang H, Yu Y, Dong Z, Zhou H
Cancer Cell Int. 2024; 24(1):356.
PMID: 39468521
PMC: 11520424.
DOI: 10.1186/s12935-024-03541-9.
Advanced technologies for the development of infectious disease vaccines.
Gupta A, Rudra A, Reed K, Langer R, Anderson D
Nat Rev Drug Discov. 2024; 23(12):914-938.
PMID: 39433939
DOI: 10.1038/s41573-024-01041-z.
An Andrias davidianus derived composite hydrogel with enhanced antibacterial and bone repair properties for osteomyelitis treatment.
Yin C, Deng M, Yu J, Chen Y, Zheng K, Huang Y
Sci Rep. 2024; 14(1):24626.
PMID: 39426986
PMC: 11490572.
DOI: 10.1038/s41598-024-75997-8.
Advancements in Drug Delivery Systems for the Treatment of Sarcopenia: An Updated Overview.
Najm A, Moldoveanu E, Niculescu A, Grumezescu A, Beuran M, Gaspar B
Int J Mol Sci. 2024; 25(19).
PMID: 39409095
PMC: 11476378.
DOI: 10.3390/ijms251910766.
Host combats porcine reproductive and respiratory syndrome virus infection at non-coding RNAs level.
Qin Z, Liu W, Qin Z, Zhang H, Huang X
Virulence. 2024; 15(1):2416551.
PMID: 39403796
PMC: 11492689.
DOI: 10.1080/21505594.2024.2416551.
Intraperitoneal administration of adeno-associated virus encoding microRNA-29b for the treatment of peritoneal metastasis.
Kaneko Y, Ohzawa H, Kimura Y, Takahashi R, Matsumiya M, Tamura K
Cancer Gene Ther. 2024; 31(12):1818-1830.
PMID: 39390194
DOI: 10.1038/s41417-024-00837-w.
Selective deuteration of an RNA:RNA complex for structural analysis using small-angle scattering.
Munsayac A, Leite W, Hopkins J, Hall I, ONeill H, Keane S
bioRxiv. 2024; .
PMID: 39314299
PMC: 11419110.
DOI: 10.1101/2024.09.09.612093.
Breaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome.
Mrksich K, Padilla M, Mitchell M
Adv Drug Deliv Rev. 2024; 214:115446.
PMID: 39293650
PMC: 11900896.
DOI: 10.1016/j.addr.2024.115446.
Glucose metabolism in glioma: an emerging sight with ncRNAs.
Rong J, Wang Q, Li T, Qian J, Cheng J
Cancer Cell Int. 2024; 24(1):316.
PMID: 39272133
PMC: 11395608.
DOI: 10.1186/s12935-024-03499-8.
Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma.
Wang C, Zhang Y, Kong W, Rong X, Zhong Z, Jiang L
Int J Nanomedicine. 2024; 19:8641-8660.
PMID: 39188861
PMC: 11346496.
DOI: 10.2147/IJN.S471900.